Will leverage PolyPeptide’s peptide manufacturing and development services and Lifecore’s formulation, fill/finish, and packaging services.

Lifecore Biomedical, Inc., a an integrated CDMO, and PolyPeptide Laboratories, Inc ., a global peptide contract development and manufacturer, entered a collaboration agreement aimed at providing an ...

According to DataM Intelligence, the Glucagon-like Peptide-1 (GLP-1) Analogues Market is witnessing a transformative ...

Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), and PolyPeptide Laboratories, Inc. (“PolyPeptide”), a global ...

Sai Life Sciences Limited has announced a new CMC Process R&D Center at its Hyderabad campus, set to double its Process R&D ...

Sai Life Sciences announces the groundbreaking of a state-of-the-art CMC Process R&D Center in Hyderabad, poised to double ...

Arch Biopartners (($TSE:ARCH)) announced an update on their ongoing clinical study. Arch Biopartners is conducting a Phase 2 global study titled ...

Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing endoscop ...

The latest update is out from Pangea Natural Food, Inc. ( (TSE:PNGA) ).

Pangea Natural Foods Inc.  (CSE:PNGA) (OTC: PNGAF) (" Pangea " or the " Company"), is excited to announce that its wholly ...

Durham, North Carolina, October 20th, 2025, FinanceWireMicropep Technologies, an agtech company specializing in ...